Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 8 to 12, 2021. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 8 to 12, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Therapeutic Heparin May Benefit Moderately Ill COVID-19 Inpatients
FRIDAY, Nov. 12, 2021 (HealthDay News) — Moderately ill COVID-19 inpatients with increased D-dimer levels receiving therapeutic heparin compared with prophylactic heparin did not have a reduction in the primary outcome of death, mechanical ventilation, or intensive care unit admission at 28 days, but they did have decreased odds of death, according to a study published online Oct. 14 in The BMJ.
Wealthier Parents More Likely to Get COVID-19 Vaccines for Young Children
FRIDAY, Nov. 12, 2021 (HealthDay News) — In a finding that suggests a family’s income influences parents’ views on COVID-19 vaccines for their younger children, a new survey shows the more money parents make, the likelier they are to get their children vaccinated.
Federal Judge Overturns Texas Ban on School Mask Mandates
FRIDAY, Nov. 12, 2021 (HealthDay News ) — A Texas ban on mask mandates in schools violates the rights of students with disabilities, a federal judge ruled Wednesday. The decision opens the door for school districts in the state to issue their own mask policies that could affect more than 5 million students, The New York Times reported.
More Than 2 Million COVID-19 Home Test Kits Recalled Due to False-Positive Results
FRIDAY, Nov. 12, 2021 (HealthDay News) — A recall of Ellume at-home COVID-19 test kits has been expanded to include roughly 2 million of the 3.5 million tests that had been shipped to the United States by last month, the U.S. Food and Drug Administration said Tuesday.
Nearly 900,000 U.S. Children Under 12 Have Gotten Their First COVID-19 Shot
WEDNESDAY, Nov. 10, 2021 (HealthDay News) — About 900,000 U.S. children aged 5 to 11 years received their initial dose of the Pfizer COVID-19 vaccine during the first week of eligibility for that age group, the Biden administration said Wednesday. Not only that, nearly 700,000 more are scheduled in the coming days, health officials added.
Pfizer Asks FDA to Approve Booster Shots for All U.S. Adults
WEDNESDAY, Nov. 10, 2021 (HealthDay News) — As concerns mount that holiday travel and indoor gatherings will foster the spread of COVID-19, Pfizer on Tuesday asked the U.S. Food and Drug Administration to approve booster shots of its COVID-19 vaccine for any American aged 18 years and older.
CPAP, HFNO Not Tied to Greater SARS-CoV-2 Air, Surface Contamination
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
Social Media Warnings Could Discourage Use Among Teens, Young Adults 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Digital Behavioral Health Game Reduces Depressive Symptoms in Teens .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
.jpeg)
